| Publication |
Sentence |
Publish Date |
Extraction Date |
Species |
| S Raskin, G Katz, Z Zislin, H Y Knobler, R Durs. Clozapine and risperidone: combination/augmentation treatment of refractory schizophrenia: a preliminary observation. Acta psychiatrica Scandinavica. vol 101. issue 4. 2000-07-14. PMID:10782556. |
clozapine and risperidone were the first two antipsychotic drugs of a new class of agents for the pharmacotherapy of schizophrenia. |
2000-07-14 |
2023-08-12 |
Not clear |
| E Kennedy, F Song, R Hunter, A Clarke, S Gilbod. Risperidone versus typical antipsychotic medication for schizophrenia. The Cochrane database of systematic reviews. issue 2. 2000-07-06. PMID:10796543. |
risperidone versus typical antipsychotic medication for schizophrenia. |
2000-07-06 |
2023-08-12 |
Not clear |
| L de Haan, J Lavalaye, D Linszen, P M Dingemans, J Booi. Subjective experience and striatal dopamine D(2) receptor occupancy in patients with schizophrenia stabilized by olanzapine or risperidone. The American journal of psychiatry. vol 157. issue 6. 2000-06-29. PMID:10831489. |
subjective experience and striatal dopamine d(2) receptor occupancy in patients with schizophrenia stabilized by olanzapine or risperidone. |
2000-06-29 |
2023-08-12 |
Not clear |
| L de Haan, J Lavalaye, D Linszen, P M Dingemans, J Booi. Subjective experience and striatal dopamine D(2) receptor occupancy in patients with schizophrenia stabilized by olanzapine or risperidone. The American journal of psychiatry. vol 157. issue 6. 2000-06-29. PMID:10831489. |
the authors' goal was to study the relationship between subjective experience during treatment with olanzapine or risperidone and dopamine d(2) receptor occupancy in stabilized patients with schizophrenia. |
2000-06-29 |
2023-08-12 |
Not clear |
| S Hiros. Effectiveness of risperidone in simple schizophrenia: a single case report. The Journal of clinical psychiatry. vol 61. issue 4. 2000-06-02. PMID:10830153. |
effectiveness of risperidone in simple schizophrenia: a single case report. |
2000-06-02 |
2023-08-12 |
Not clear |
| H Y Lane, W C Chiu, J C Chou, S T Wu, M H Su, W H Chan. Risperidone in acutely exacerbated schizophrenia: dosing strategies and plasma levels. The Journal of clinical psychiatry. vol 61. issue 3. 2000-05-25. PMID:10817107. |
risperidone in acutely exacerbated schizophrenia: dosing strategies and plasma levels. |
2000-05-25 |
2023-08-12 |
Not clear |
| H Y Lane, W C Chiu, J C Chou, S T Wu, M H Su, W H Chan. Risperidone in acutely exacerbated schizophrenia: dosing strategies and plasma levels. The Journal of clinical psychiatry. vol 61. issue 3. 2000-05-25. PMID:10817107. |
the optimal risperidone dosing strategy for acute schizophrenia requires elucidation. |
2000-05-25 |
2023-08-12 |
Not clear |
| H Y Lane, W C Chiu, J C Chou, S T Wu, M H Su, W H Chan. Risperidone in acutely exacerbated schizophrenia: dosing strategies and plasma levels. The Journal of clinical psychiatry. vol 61. issue 3. 2000-05-25. PMID:10817107. |
we thus investigated whether dose reduction to diminish adverse reactions associated with ordinary risperidone doses could still yield efficacy for acutely exacerbated schizophrenia. |
2000-05-25 |
2023-08-12 |
Not clear |
| S Madhusoodanan, M Brecher, R Brenner, J Kasckow, M Kunik, A E Negrón, N Pomar. Risperidone in the treatment of elderly patients with psychotic disorders. The American journal of geriatric psychiatry : official journal of the American Association for Geriatric Psychiatry. vol 7. issue 2. 2000-05-04. PMID:10322240. |
the authors evaluated the safety, tolerability, and efficacy of risperidone in 103 elderly patients (mean age, 71 years) with schizophrenia (75%) or schizoaffective disorder (25%). |
2000-05-04 |
2023-08-12 |
Not clear |
| S Madhusoodanan, M Brecher, R Brenner, J Kasckow, M Kunik, A E Negrón, N Pomar. Risperidone in the treatment of elderly patients with psychotic disorders. The American journal of geriatric psychiatry : official journal of the American Association for Geriatric Psychiatry. vol 7. issue 2. 2000-05-04. PMID:10322240. |
risperidone was well tolerated and efficacious in elderly patients with schizophrenia or schizoaffective disorder. |
2000-05-04 |
2023-08-12 |
Not clear |
| D H Nieman, L J Bour, D H Linszen, J Goede, J H Koelman, B P Gersons, B W Ongerboer de Visse. Neuropsychological and clinical correlates of antisaccade task performance in schizophrenia. Neurology. vol 54. issue 4. 2000-03-29. PMID:10690978. |
to elucidate pathophysiologic mechanisms involved in abnormal antisaccade task performance in schizophrenia by investigating a possible relationship among antisaccade task performance, neuropsychological test results, and symptomatology in a group of young patients with recent-onset schizophrenia; to compare the effects of olanzapine and risperidone on antisaccades and reflexive saccades. |
2000-03-29 |
2023-08-12 |
Not clear |
| P E Keck, S M Strakowski, S L McElro. The efficacy of atypical antipsychotics in the treatment of depressive symptoms, hostility, and suicidality in patients with schizophrenia. The Journal of clinical psychiatry. vol 61 Suppl 3. 2000-03-22. PMID:10724127. |
for this article, the available literature regarding the efficacy of clozapine, risperidone, olanzapine, quetiapine, and ziprasidone in the treatment of depression, hostility, and suicidality in patients with schizophrenia was reviewed. |
2000-03-22 |
2023-08-12 |
Not clear |
| S E Purdon, B D Jones, E Stip, A Labelle, D Addington, S R David, A Breier, G D Tollefso. Neuropsychological change in early phase schizophrenia during 12 months of treatment with olanzapine, risperidone, or haloperidol. The Canadian Collaborative Group for research in schizophrenia. Archives of general psychiatry. vol 57. issue 3. 2000-03-21. PMID:10711911. |
neuropsychological change in early phase schizophrenia during 12 months of treatment with olanzapine, risperidone, or haloperidol. |
2000-03-21 |
2023-08-12 |
Not clear |
| T Nagasaki, T Ohkubo, K Sugawara, N Yasui, H Furukori, S Kanek. Determination of risperidone and 9-hydroxyrisperidone in human plasma by high-performance liquid chromatography: application to therapeutic drug monitoring in Japanese patients with schizophrenia. Journal of pharmaceutical and biomedical analysis. vol 19. issue 3-4. 2000-03-17. PMID:10704125. |
determination of risperidone and 9-hydroxyrisperidone in human plasma by high-performance liquid chromatography: application to therapeutic drug monitoring in japanese patients with schizophrenia. |
2000-03-17 |
2023-08-12 |
human |
| J Lavalaye, D H Linszen, J Booij, L Reneman, B P Gersons, E A van Roye. Dopamine D2 receptor occupancy by olanzapine or risperidone in young patients with schizophrenia. Psychiatry research. vol 92. issue 1. 2000-03-14. PMID:10688158. |
dopamine d2 receptor occupancy by olanzapine or risperidone in young patients with schizophrenia. |
2000-03-14 |
2023-08-12 |
Not clear |
| S K Liu, W J Chen, C J Chang, H N Li. Effects of atypical neuroleptics on sustained attention deficits in schizophrenia: a trial of risperidone versus haloperidol. Neuropsychopharmacology : official publication of the American College of Neuropsychopharmacology. vol 22. issue 3. 2000-03-13. PMID:10693159. |
effects of atypical neuroleptics on sustained attention deficits in schizophrenia: a trial of risperidone versus haloperidol. |
2000-03-13 |
2023-08-12 |
Not clear |
| R A Emsle. Risperidone in the treatment of first-episode psychotic patients: a double-blind multicenter study. Risperidone Working Group. Schizophrenia bulletin. vol 25. issue 4. 2000-03-03. PMID:10667742. |
an international, multicenter, double-blind study was conducted in 183 patients with a first psychotic episode (provisional schizophreniform disorder or schizophrenia; dsm-iii-r) treated with flexible doses of risperidone or haloperidol for 6 weeks. |
2000-03-03 |
2023-08-12 |
Not clear |
| S M Dursun, J K Patel, J G Burke, M A Revele. Effects of typical antipsychotic drugs and risperidone on the quality of sleep in patients with schizophrenia: a pilot study. Journal of psychiatry & neuroscience : JPN. vol 24. issue 4. 2000-02-29. PMID:10516800. |
effects of typical antipsychotic drugs and risperidone on the quality of sleep in patients with schizophrenia: a pilot study. |
2000-02-29 |
2023-08-12 |
Not clear |
| S M Dursun, J K Patel, J G Burke, M A Revele. Effects of typical antipsychotic drugs and risperidone on the quality of sleep in patients with schizophrenia: a pilot study. Journal of psychiatry & neuroscience : JPN. vol 24. issue 4. 2000-02-29. PMID:10516800. |
to investigate the effects of a newer antipsychotic drug, risperidone (a potent serotonin 5-ht2a/2c and dopamine d2-receptor blocker), on the quantity and quality of sleep in patients with schizophrenia. |
2000-02-29 |
2023-08-12 |
Not clear |
| K S Earnst, S F Taylor, I C Smet, R S Goldman, R Tandon, S Beren. The effects of typical antipsychotics, clozapine, and risperidone on neuropsychological test performance in schizophrenia. Schizophrenia research. vol 40. issue 3. 2000-02-18. PMID:10638864. |
the effects of typical antipsychotics, clozapine, and risperidone on neuropsychological test performance in schizophrenia. |
2000-02-18 |
2023-08-12 |
Not clear |